
redaccionmedica.com
Jun 28, 2025, 05:13
Raul Cordoba Highlights Study on Pre-Phase Treatment with Rituximab and Methotrexate for CNS Lymphoma Patients
Raul Cordoba, Associate Chief at the Department of Hematology at Jiménez Díaz Foundation, shared an article on X Julia Wendler and colleagues authored:
“Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma.”
Title: Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma
Authors: Julia Wendler, Richard I. Lewis, Alexandra Kutilina, Markus Knott, Lisa Kristina Isbell, Elke Valk, Peter Borchmann, Jan-Michel Heger, Gerald Illerhaus, Elisabeth Schorb
Journal: Haemotoligica
More posts featuring Raul Cordoba.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 28, 2025, 04:52
Jun 28, 2025, 04:32
Jun 28, 2025, 04:20
Jun 28, 2025, 04:17
Jun 27, 2025, 18:17
Jun 27, 2025, 17:50